Merck & Co.
Merck develops and produces medicines, vaccines, biologic therapies and animal health products.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | $231k | Post IPO Equity | |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 1 % | 22 % | 1 % | 7 % | 1 % | 6 % | 5 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 28 % | 31 % | 13 % | 41 % | 46 % | 48 % | 48 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 27 % | 24 % | 1 % | 27 % | 31 % | 32 % | 33 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 25 % | 23 % | 51 % | 28 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Merck & Co., Inc., headquartered in Kenilworth, N.J., is a global healthcare company dedicated to following the science to tackle some of the world's greatest health threats. The company focuses on developing innovative medicines and vaccines for a wide range of health issues, including cardiovascular disease, diabetes, and cancer. Merck serves a diverse clientele, including patients, healthcare professionals, and institutions worldwide. Operating in the pharmaceutical and biotechnology markets, Merck's business model revolves around extensive research and development (R&D) to create new treatments and therapies. The company generates revenue primarily through the sale of prescription medicines, vaccines, and animal health products. Additionally, Merck offers patient assistance programs to provide free medicines and vaccines to qualified patients, and professional resources through platforms like Merck Connect and Merck Manuals.
Keywords: healthcare, pharmaceuticals, vaccines, R&D, cardiovascular, diabetes, cancer, patient assistance, global, biotechnology.
Tech stack
